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Objective: To assess the knowledge on Zika virus infection among healthcare providers
(doctors) in Aceh province, Indonesia.
Methods: A self-administered internet based survey was conducted from 3 May to 3
June 2016 among the members of doctor organizations in Aceh province. A set of
validated, pre-tested questionnaire was used to measure knowledge regarding Zika
infection and to collect a range of explanatory variables. A two-steps logistic regression
analysis was employed to assess the association of participants' demographic, workplace
characteristics and other explanatory variables with the knowledge.
Results: A total of 442 participants included in the ﬁnal analysis and 35.9% of them
(159) had a good knowledge on Zika infection. Multivariate model revealed that type of
occupation, type of workplace, availability of access to medical journals and experience
made Zika disease as differential diagnose were associated with knowledge on Zika
infection. In addition, three signiﬁcant source of information regarding Zika were online
media (60%), medical article or medical news (16.2%) and television (13.2%).
Conclusion: The knowledge of the doctors in Aceh regarding Zika infection is relatively
low. Doctors who have a good knowledge on Zika infection are more conﬁdent to
established Zika disease as differential diagnosis in their clinical setting. Therefore, such
program to increase healthcare providers' knowledge regarding Zika infection is needed
to screen potential carriers of Zika infection.1. Introduction
In 2007, the ﬁrst Zika fever outbreak was reported in the
Federated States of Micronesia [1]. Subsequent infections of Zika
Virus (ZIKV) were not reported until an outbreak occurred in
French Polynesia in 2013 followed in New Caledonia, CookIslands, and Easter Island in 2014 and in Vanuatu, Solomon
Islands, Samoa, and Fiji in 2015 [2]. In May 2015, for the ﬁrst
time, ZIKV emerged in America [3]. On February 1, 2016,
WHO declared ZIKV infection as a public health emergency
of international concern and in the early of May 2016, 58
countries and territories reported continuing mosquito-borne
transmission of ZIKV, most of them in the Americas [4].
ZIKV infection has been mainly associated with microcephaly
and other central nervous system birth defects [5,6] and it has
been linked to more than 4.000 recent microcephaly cases in
Brazil as well some cases in Colombia and Venezuela [7]. Inrticle under the CC BY-NC-ND license (http://
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Barre Syndrome [8].
In Indonesia, the ﬁrst Zika case with serologic evidence, was
reported in 1981 in Central Java [9]. In 1983, a survey in
Lombok indicated that 12.7% (9/71) of the human serum
samples had neutralizing antibody to ZIKV using a
hemagglutination inhibition test [10]. In 2013, a traveler
acquired ZIKV infection during a visit in Jakarta [11] and in
2015, a traveler returning to Australia developed Zika fever
after a monkey bite in Bali [12]. For the ﬁrst time, in 2016,
ZIKV was isolated from a febrile patient during a 2015
dengue outbreak in Jambi province [13].
Co-circulation of ZIKV with dengue virus and chikungunya
virus has been documented in some regions [14,15] and this is
likely also occurs throughout the Asia and other regions where
dengue virus and chikungunya virus are endemic [2]. Even,
triple coinfections (dengue, chikungunya and Zika viruses)
have recently documented in Colombia [16,17]. Moreover, it is
now clear that ZIKV is following the path of dengue virus and
chikungunya virus, spreading to all countries infested with
Aedes aegypti and Aedes albopictus mosquitoes, but probably
with other vectors involved (e.g. Culex) [18]. Indonesia is one
of the largest countries in the dengue endemic [19] and
chikungunya outbreaks have occurred throughout Indonesia
[20–22]. Therefore, Indonesia might be a vulnerable country for
ZIKV outbreak.
ZIKV infection has become a major public health concern
worldwide and it has potential to cause a pandemic. Therefore, it
is important for healthcare workers to have sufﬁcient knowledge
to screen potential carriers in their clinical settings. WHO expert
meetings have identiﬁed gaps in knowledge about ZIKV,
potentially related complications and effective interventions and
WHO has released the resource information pack of knowledge,
attitudes and practice survey for ZIKV disease and potential
complications [23]. Up to today, data regarding knowledge,
attitude and practice towards ZIKV infection among healthcare
workers is limited. Therefore, the aim of this study was to
assess the knowledge on ZIKV infection among doctors in
Aceh province, Indonesia.
2. Materials and methods
2.1. Ethical clearance
The Ethical Clearance Committee of the School of Medicine,
Syiah Kuala University, Banda Aceh, Indonesia approved this
study protocol (approval 19/KE/FK/2016). A brief explanation
of the study was given to all participants and informed concern
was obtained from all participants prior to enrollment. Partici-
pation was voluntary, anonymous, and no direct ﬁnancial
compensation was offered.
2.2. Survey design and study instrument
To assess the knowledge regarding Zika infection, a self-
administered internet based survey was conducted from 3 May
to 3 June 2016. A link to online questionnaire was sent to doctor
organizations in Aceh province and the survey was forwarded to
member via social media. The remainders were sent each week
after the initial invitation. It required approximately 8–12 min
completing the survey.The questions within knowledge domain were designed
based on information provided by Centers for Disease Control
and Prevention [24]. The questionnaire also covered a range of
explanatory variables (basic demographic data, education
attainment, type of workplace, characteristics of the workplace
and the experience related to Zika disease). In addition, the
sources of information regarding Zika were also collected. A
reliability test of questionnaires within knowledge domain,
consisting eleven questions, was conducted among 30
participants prior the study. The Cronbach's alpha score was




To measure the knowledge regarding the cause, sign and
symptom, diagnosis, treatment, prevention, transmission and
risk of the Zika infection, a set of 11-questions questionnaire
was used. The possible responses to all of the questions were
“yes” or “no” and there was no “do not know” option provided.
Correct answers were given a score of one, and incorrect ones,
zero. The knowledge of a participant was computed as the total
sum of correct responses such that higher score indicated a better
knowledge regarding Zika infection.
2.3.2. Explanatory variables
Data on age, gender, education attainment and type of
occupation were collected from each participant. Information of
workplace department, location of workplace (district, regency
or capital city of province), characteristics of workplace
including the availability of certain testing procedures (PCR and
ELISA) and the availability of the access to scientiﬁc journals
were also recorded. The respondents were also asked about
experience attending medical conference or training in the last
ﬁve months and their medical experience (in year). The expe-
rience diagnosing Zika disease was collected including whether
they have diagnosed or made Zika as differential diagnosis to
their patients. Furthermore, the main sources of information
regarding Zika were collected by asking the participants to chose
from a list provided (printed media, online media, television,
radio, medical colleagues, scientiﬁc articles and medical
conference).
2.4. Statistical analysis
For each participant, the score for knowledge regarding Zika
infection was computed as the sum of the correct response
scores and the additive scale score ranged from 0 to 11. For the
statistical analysis propose, the level of knowledge was dichot-
omized into “good” and “poor” based on an 80% cut-off point.
To assess the association of participants' demographic, work-
place characteristics and other explanatory variables with the
knowledge, a two-steps logistic regression analysis was
employed. In the univariate logistic regression, all explanatory
factors were included and explanatory variables that were
associated with knowledge with a P-value  0.25 in the uni-
variate analysis were then included into the multivariate anal-
ysis. The estimated odds ratio (OR) was interpreted in relation to
one of the categories, which was designated as the reference
category [25,26]. Confounding factors were explored by
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in multivariate analyses and the crude odds ratio (OR) in
univariate analyses. All signiﬁcance tests were two tailed and
P-value of less than 0.05 was considered to be statistically
signiﬁcant. All analysis was performed using the Statistical




We received 631 participant responses during the study
period and 189 data were excluded from ﬁnal analysis due to
missing information. A total of 442 (70.04%) participants, well
distributed from regions of district, regency and the capital city
of province, were analyzed. The characteristics of the partici-
pants are presented in Table 1. The proportion of the gender was
slightly different, 42% vs. 57% for male and female, respectively
and a majority of the participants (80.1%) was general practi-
tioner. More than 90% of the participants had medical experi-
ence less than 5 years and approximately 10% have attended atTable 1
Univariate logistic regression analysis showing predictors of knowledge on
Variable n (%) Good knowle
n (%)
Gender
Male (R) 188 (42.5) 57 (30.3)
Female 254 (57.5) 102 (40.1)
Age group
Less than 30 (R) 238 (53.8) 79 (33.1)
31-40 181 (41.0) 76 (41.9)
30 or more 23 (5.2) 4 (17.3)
Education
GP (R) 354 (80.1) 132 (37.2)
GP with master or doctoral degree 35 (7.9) 17 (48.5)
Specialist 33 (7.5) 6 (18.2)
Specialist with master or doctoral degree 20 (4.5) 4 (20.0)
Occupation
GP (R) 301 (68.1) 119 (39.5)
Specialist 16 (3.6) 1 (6.3)
GP plus university staff 40 (9.1) 12 (30.0)
Specialist plus university staff 54 (12.2) 22 (40.7)
Specialist residency 31 (7.0) 5 (16.1)
Department
Community health centre (R) 152 (34.4) 72 (47.3)
Emergency unit 121 (27.4) 34 (28)
Other departmentsa 92 (20.8) 22 (23.9)
Others 77 (17.4) 31 (40.2)
Type of work place
Community health centre (R) 89 (20.1) 57 (64)
Private clinic or hospital 164 (37.1) 54 (32.9)
Government hospital 189 (42.8) 48 (25.3)
Location of workplace
District (R) 120 (27.1) 63 (52.5)
Regency 156 (35.3) 42 (26.9)
Province 166 (37.6) 54 (32.5)
Attended province level conference
No (R) 145 (32.8) 48 (33.1)
Yes 297 (67.2) 111 (37.3)
Attended national conference
No (R) 270 (61.1) 112 (41.4)
Yes (2) 172 (38.9) 47 (27.3)least one international conference in the last ﬁve months. In
general, less than 30% of the participants stated that their
workplace had either PCR or ELISA facility. Although 6.6% of
participants have contacted with patients were presented signs
and symptoms of Zika infection, only less than half of them
stated had experience making Zika infection as differential
diagnosis.
3.2. Knowledge on Zika and associated factors
We found that 159 (35.9%) participants had a good knowl-
edge on Zika infection. Univariate logistic regression analysis
revealed that gender, education attainment, type of occupation,
department, type and location of workplace, participation in
national conference within last ﬁve months, availability of ac-
cess to medical journals and experience making Zika disease as
differential diagnosis were associated with knowledge (Table 1).
However, the multivariate model revealed that only type of
occupation, type of workplace, availability of access to medical
journals and experience made Zika disease as differential di-
agnose were associated with knowledge on Zika infection
(Table 1).Zika disease (Good vs. Poor) (n = 442).
dge Univariate Multivariate
OR (95% CI) P–value OR (95% CI) P–value
1
1.54 (1.03–2.30) 0.032 1.21 (0.75–1.94) 0.421
0.034 0.668
1
1.45 (0.97–2.17) 0.065 1.28 (0.70–2.33) 0.423
0.42 (0.13–1.28) 0.424 1.93 (0.19–19.80) 0.576
0.031 0.261
1
1.58 (0.79–3.18) 0.193 1.88 (0.70–5.06) 0.207
0.37 (0.15–0.92) 0.034 4.92 (0.69–35.02) 0.111
0.42 (0.13–1.28) 0.128 3.17 (0.54–18.65) 0.200
0.020 0.109
1 1
0.10 (0.01–0.78) 0.028 0.01 (0.01–0.34) 0.008
0.65 (0.32–1.33) 0.247 0.46 (0.10–2.16) 0.330
1.05 (0.58–1.89) 0.868 0.81 (0.33–2.01) 0.664
0.29 (0.11–0.78) 0.015 0.08 (0.08–0.90) 0.410
<0.001 0.320
1 1
0.43 (0.26–0.72) 0.001 1.27 (0.53–3.03) 0.578
0.34 (0.19–0.62) <0.001 3.41 (0.71–16.31) 0.124
0.74 (0.43–1.30) 0.308 1.70 (0.76–3.78) 0.190
<0.001 0.001
1 1
0.27 (0.16–0.47) <0.001 0.22 (0.10–0.49) <0.001
0.19 (0.11–0.32) <0.001 0.18 (0.06–0.50) 0.001
<0.001 0.115
1 1
0.33 (0.20–0.55) <0.001 0.61 (0.30–1.25) 0.180
0.43 (0.26–0.70) 0.001 1.10 (0.52–2.36) 0.790
1 –
1.20 (0.79–1.83) 0.380 – –
1 1
0.53 (0.35–0.80) 0.003 0.74 (0.43–1.27) 0.287
(continued on next page)
Table 1 (continued )
Variable n (%) Good knowledge
n (%)
Univariate Multivariate
OR (95% CI) P–value OR (95% CI) P–value
Attended international conference
No (R) 398 (90.0) 147 (36.9) 1 1
Yes 44 (10.0) 12 (27.2) 0.64 (0.32–1.28) 0.208 1.27 (0.51–3.15) 0.605
Medical experience (year) 0.002 0.072
1–2 (R) 159 (36.0) 47 (29.5) 1 1
3–4 250 (56.6) 108 (43.2) 1.81 (1.18–2.76) 0.006 1.66 (0.93–2.94) 0.081
11–15 16 (3.6) 2 (12.5) 0.34 (0.07–1.55) 0.165 0.30 (0.04–1.92) 0.206
More than 15 17 (3.8) 2 (11.8) 0.31 (0.07–1.44) 0.138 0.20 (0.01–3.40) 0.268
Workplace has PCR facility
No (R) 359 (81.5) 133 (37) 1 –
Yes 83 (18.8) 26 (31.3) 0.77 (0.46–1.29) 0.328 – –
Workplace has ELISA facility
No (R) 340 (76.9) 126 (37) 1 –
Yes 102 (23.1) 33 (32.3) 0.81 (0.50–1.29) 0.386 – –
Workplace has access to medical journals
No (R) 322 (72.9) 130 (40.3) 1 1
Yes 120 (27.1) 29 (24.1) 0.47 (0.29–0.75) 0.002 0.38 (0.20–0.73) 0.003
Had contact with patient(s) presenting signs and symptoms of Zika
No (R) 413 (9.4) 145 (35.1) 1 1
Yes 29 (6.6) 14 (48.2) 1.72 (0.81–3.67) 0.157 1.33 (0.53–3.37) 0.535
Had experienced making Zika as differential diagnose
No (R) 429 (97.1) 150 (35.0)
Yes 13 (2.9) 9 (69.2) 4.18 (1.26–13.81) 0.019 10.66 (2.35–48.19) 0.002
CI: conﬁdence interval, ELISA: enzyme-linked immunosorbent assay, GP: general practitioner, OR: odds ratio, PCR: polymerase chain reaction, R:
reference group.
a Including pediatric, obstetrics and gynecology, surgery, internal medicine, pulmonology, neurology and others.
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double job as teaching staff) had lower odds of having a good
knowledge on Zika infection compared to general practitioners
(OR: 0.01; 95% CI: 0.01–0.34). Compared to doctors who were
working in community health centers, the odds of having a good
knowledge decreased among doctors who were working in
private clinics or private hospitals (OR: 0.22; 95% CI: 0.10–
0.49) or in the governmental hospitals (OR: 0.18; 95% CI: 0.06–
0.50). In addition, as expected, doctors who had experience
diagnosing at least one patient with differential diagnosis of Zika
disease had signiﬁcant higher odds having a good knowledge,
approximately 11 times. Interestingly, having access to medical
journals was associated with a poor knowledge.
3.3. Source of information
We included 462 participants to assess the main source of
information regarding Zika infection. Approximately 60% of the
participants received the information from online media fol-
lowed by medical article or medical news (16.2%) and television
(13.2%). Printed media seems had no signiﬁcant role as infor-
mation source regarding Zika. In addition, only less than 5% of
the participants received Zika information by attending medical
seminar.
4. Discussion
There is enough evidence to indicate that Zika virus is pre-
sent in Indonesia. Zika infection has been conﬁrmed from a
patient in Indonesia [13] or from travelers returning from
Indonesia [11,12]. However, there is no study has been
conducted to assess the knowledge of healthcare workers in
the country for this new emerging infectious disease. This
study was conducted to assess the knowledge on Zikainfection among doctors in Aceh province, Indonesia. We
found that only 35.9% of the participants had good knowledge
and being general practitioner, working in community health
centers and had experience making a difference diagnose of
Zika disease to patient(s) were associated with good knowledge.
Currently, reports regarding knowledge on Zika infection
have been published among dental practitioners in India [27] and
healthcare students and workers in Colombia [28,29]. In India, the
study tried to assess the factors associated with knowledge on
Zika infection and found that qualiﬁcation of dental
practitioners was associated with knowledge [27]. In this
present study, education attainment had no association with
knowledge regarding Zika infection. There are, at least, two
explanations. First, Zika infection is a new emerging
infectious disease and therefore it has not been included in the
medical curriculum even in higher qualiﬁcation in medical
education system. Second, our study reveled that online media
was the most predominant information source of the
information related to Zika infection. In context of Aceh and
Indonesia, the senior healthcare workers are less active in
accessing online media compared to their junior counterparts.
These explain that higher medical education had no
association with a better knowledge on Zika infection. The
second explanation might also explain the ﬁnding that being
general practitioners had signiﬁcant higher odds of having
good knowledge on Zika infection.
In addition, having contacted with patients presenting the
signs and symptoms of Zika disease also had no association with
knowledge on Zika infection. Interestingly, 13 of the partici-
pants had experienced making Zika disease as differential
diagnosis to their patients and this associated with higher
knowledge on Zika disease. Indonesia is a hyper-endemic
country for dengue including Aceh province and chikungunya
outbreak has been reported previously in Aceh [20]. In fact, the
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dengue and chikungunya infection [30]. Although, those
patients could be dengue infection, it should be noted that, the
ﬁrst conﬁrmed Zika patient in Jambi province was also
suspected as dengue patient [13]. In addition, there is no
established diagnostic system for Zika in Aceh, indeed in
Indonesia. These might cause Zika infection could be missed
being diagnosed during clinical visit.
We also found that general practitioners had higher odds of
having a good knowledge compared to specialist doctors and
doctor who were working in community health centers had
better good knowledge compared to those who were working in
private clinics or private hospitals or in the governmental hos-
pitals. The explanation for these ﬁndings may be underpinned
by two plausible reasons: the nature of ZIKV diagnosis and the
survey respondent's characteristic. As the clinical symptoms of
Zika disease highly resemble other arbovirus diseases such as
dengue and chikungunya, as well other tropical diseases (e.g.
malaria), detections of Zika disease may be regarded within
general practitioner competence. General practitioners would
feel that they are expected to have a sufﬁcient knowledge about
Zika disease, as well as other arbovirus diseases, which is
outlined in the Indonesian Standard of General Practitioners
Competence (SKDI) and would try to ﬁnd information
regarding Zika. This might result in better knowledge of Zika
amongst general practitioner. Most of Zika prevention mea-
sures, including the strategic response set out by WHO (mos-
quito control/risk communications/community engagement) are
also within the community health centre area of work, where
general practitioners are based. Government hospitals role may
be limited to referral centre for advanced cases and private
clinics were not involved in strategic response for arbovirus
diseases as much as community health centre. In addition,
specialization department that is associated with the manage-
ment of Zika disease as recommended by CDC includes
obstetric-gynecologist and pediatrician. However, the numbers
of specialist doctors from these departments who participate in
the survey are signiﬁcantly less than the number of general
practitioners or other specialist doctor, which may affect the
ﬁnal result.
Finally, as expected, doctors who had experience diagnosing
at least one patient with differential diagnosis of Zika disease
had signiﬁcant higher odds having a good knowledge. Inter-
estingly, having access to medical journals was associated with a
poor knowledge. The ability to established Zika disease as dif-
ferential diagnosis is associated with better knowledge of ZIKV,
because it requires speciﬁc information to differentiate diagnosis
of Zika disease and other similar arbovirus diseases.
The knowledge of the doctors in Aceh regarding Zika disease
is relatively low; approximately only 40% participants who had
a good knowledge on Zika infection. General practitioners have
a higher knowledge compared to specialist and doctors who are
working in community health centers also have a better
knowledge compared to their counterparts in private clinics or
private hospitals or in the governmental hospitals. Doctors know
have a good knowledge are more conﬁdent to established Zika
disease as differential diagnosis in their clinical setting.
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